TY - JOUR
T1 - Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R
AU - Della Porta, Matteo G.
AU - Alessandrino, Emilio Paolo
AU - Bacigalupo, Andrea
AU - Van Lint, Maria Teresa
AU - Malcovati, Luca
AU - Pascutto, Cristiana
AU - Falda, Michele
AU - Bernardi, Massimo
AU - Onida, Francesco
AU - Guidi, Stefano
AU - Iori, Anna Paola
AU - Cerretti, Raffaella
AU - Marenco, Paola
AU - Pioltelli, Pietro
AU - Angelucci, Emanuele
AU - Oneto, Rosi
AU - Ripamonti, Francesco
AU - Bernasconi, Paolo
AU - Bosi, Alberto
AU - Cazzola, Mario
AU - Rambaldi, Alessandro
PY - 2014/4/10
Y1 - 2014/4/10
N2 - Approximately one-third of patients with myelodysplastic syndrome (MDS) receiving allogeneic hematopoietic stem cell transplantation (HSCT) are cured by this treatment. Treatment failure maybe due to transplant complications or relapse. To identify predictive factors for transplantation outcome, we studied 519 patients with MDS or oligoblastic acute myeloid leukemia (AML,
AB - Approximately one-third of patients with myelodysplastic syndrome (MDS) receiving allogeneic hematopoietic stem cell transplantation (HSCT) are cured by this treatment. Treatment failure maybe due to transplant complications or relapse. To identify predictive factors for transplantation outcome, we studied 519 patients with MDS or oligoblastic acute myeloid leukemia (AML,
UR - http://www.scopus.com/inward/record.url?scp=84901701732&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84901701732&partnerID=8YFLogxK
U2 - 10.1182/blood-2013-12-542720
DO - 10.1182/blood-2013-12-542720
M3 - Article
C2 - 24558201
AN - SCOPUS:84901701732
VL - 123
SP - 2333
EP - 2342
JO - Blood
JF - Blood
SN - 0006-4971
IS - 15
ER -